Visit-to-visit blood pressure variations: New independent determinants for cognitive function in the elderly at high risk of cardiovascular disease

Journal of Hypertension

Volumn 30, Issue 8, 2012, Pages 1556-1563

  Nagai, Michiaki ^a,b   Hoshide, Satoshi ^a   Ishikawa, Joji ^a   Shimada, Kazuyuki ^a   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Shobara City Soryo Clinic   (Japan)

Author keywords

cognitive function; cognitive impairment; the elderly; visit to visit blood pressure variability

Indexed keywords

AGED; ARTICLE; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITION; COHORT ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; SCORING SYSTEM; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 84863834121     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283552735     Document Type: Article

References (39)

1. Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C, For the UKTIA Collaborative Group. Blood pressure and risk of stroke in patients with cerebrovascular disease. BMJ 1996; 313:147.
2. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
3. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375:938-948.
4. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens 2011; 5:184-192.
5. Brickman AM, Reitz C, Luchsinger JA, Manly JJ, Schupf N, Muraskin J, et al. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol 2010; 67:564-569.
6. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347:1141-1145.
7. Stewart R, Xue QL, Masaki K, Petrovitch H, Ross GW, et al. Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension 2009; 54:233-240.
8. McGuinness B, Todd S, Passmore P, Bullock R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev 2006; 2:CD004034.
9. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, et al. Incident dementia and blood pressure lowering in the hypertension in the very elderly trial cognitive function assessment (HYVET-COG): a doubleblind, placebo-controlled trial. Lancet Neurol 2008; 7:683-689.
10. Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, et al. Prevention of dementia by antihypertensive drugs: how AT1-receptorblockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors. Expert Rev Neurother 2009; 9:1413-1431.
11. Qiu C, von Strauss E, Winblad B, Fratiglioni L. Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen project. Stroke 2004; 35:1805-1810.
12. Sakakura K, Ishikawa J, Okuno M, Shimada K, Kario K. Exaggerated ambulatory blood pressure variability is associated with cognitive function in the very elderly and quality of life in the younger elderly. Am J Hypertens 2007; 20:720-727.
13. Cleeman JI, Lenfant C. New guidelines for the treatment of high blood cholesterol in adults from the National Cholesterol Education Program, From controversy to consensus. Atherosclerosis 1987; 7:649-650.
14. Kario K, Hoshide S, Shimizu M, Yano Y, Eguchi K, Ishikawa J, et al. Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens 2010; 28:1574-1583.
15. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
16. Lezak MD, Howieson DB, Loring DW. Neuropsychological assessment. 4th ed. Oxford: Oxford University Press; 2004.
17. Reisberg B, Ferris SH, de Leon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139:1136-1139.
18. Yamasaki Y, Katakami N, Sakamoto K, Kaneto H, Matsuhisa M, Sato H, et al. Combination of multiple genetic risk factors is synergistically associated with carotid atherosclerosis in Japanese subjects with type 2 diabetes. Diabetes Care 2006; 29:2445-2451.
19. Yamasaki Y, Katakami N, Furukado S, Kitagawa K, Nagatsuka K, Kashiwagi A, et al. Long-term effects of pioglitazone on carotid atherosclerosis in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity. J Atheroscler Thromb 2010; 17:1132-1140.
20. Emoto M, Nishizawa Y, Kawagishi T, Maekawa K, Hiura Y, Kanda H, et al. Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM. Diabetes Care 1998; 21:1178-1182.
21. Kawasaki T, Sasayama S, Yagi S, Asakawa T, Hirai T. Noninvasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc Res 1987; 21:678-687.
22. Hirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation 1989; 80:78-86.
23. Brickman AM, Muraskin J, Zimmerman ME. Structural neuroimaging in Alzheimer's disease: do white matter hyperintensities matter? Dialogues Clin Neurosci 2009; 11:181-190.
24. Brickman AM, Honig LS, Scarmeas N, Tatarina O, Sanders L, Albert MS, et al. Measuring cerebral atrophy and white matter hyperintensity burden to predict rate of cognitive decline in Alzheimer disease. Arch Neurol 2008; 65:1202-1208.
25. Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, et al. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol 2008; 65:94-100.
26. Wendell CR, Zonderman AB, Metter EJ, Najjar SS, Waldstein SR. Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease. Stroke 2009; 40:3180-3185.
27. Crouse JR, Goldbourt U, Evans G, Pinsky J, Sharrett AR, Sorlie P, et al. Risk factors and segmentspecific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1996; 27:69-75.
28. Whisnant JP, Homer D, Ingall TJ, Baker HL, O'Fallon WM, Wiebers DO. Duration of cigarette smoking is the strongest predictor of severe extracranial carotid artery atherosclerosis. Stroke 1990; 21:707-714.
29. Szirmai IG, Kamondi A, Magyar H, Juhasz C. Relation of laboratory and clinical variables to the grade of carotid atherosclerosis. Stroke 1993; 24:1811-1816.
30. Lakka TA, Salonen R, Kaplan GA, Salonen JT. Blood pressure and the progression of carotid atherosclerosis in middle-aged men. Hypertension 1999; 34:51-56.
31. Zanchetti A. Intermediate endpoints for atherosclerosis in hypertension. Blood Press Suppl 1997; 2:97-102.
32. Omboni S, Parati G, Di Rienzo M, Wieling W, Mancia G. Blood pressure and heart rate variability in autonomic disorders: a critical review. Clin Auton Res 1996; 6:171-182.
33. Kingwell BA, Cameron JD, Gillies KJ, Jennings GL, Dart AM. Arterial compliance may influence baroreflex function in athletes and hypertensives. Am J Physiol 1995; 268:H411-H418.
34. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: Findings from NHANESIII, 1988 to 1994. Hypertension 2011; 57:160-166.
35. Grove JS, Reed DM, Yano K, Hwang LJ. Variability in systolic blood pressure-a risk factor for coronary heart disease? Am J Epidemiol 1997; 145:771-776.
36. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebocontrolled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352:1347-1351.
37. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, et al. Effects of b blockers and calcium-channel blockers on withinindividual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9:469-480.
38. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensivedrug class on interindividual variation in blood pressure and risk of stroke: a systematic reviewandmeta-analysis. Lancet 2010; 375:906-915.
39. Wang JG, Staessen JA, Li Y, Van Bortel LM, Nawrot T, Fagard R, et al. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke 2006; 37:1933-1940.